US stock futures muted with Jackson Hole, retail earnings on tap
LONDON - Carr’s Group plc (LSE:CARR) has entered into a strategic manufacturing partnership with French company Vétalis to develop an advanced range of Tracesure® boluses, according to a press release issued Friday.
The partnership follows Carr’s decision to close its ANIMAX production facility in June 2025. Distribution of the new products is scheduled to begin in Autumn 2025.
Under the agreement, Carr’s will leverage Vétalis’ manufacturing capabilities while focusing its own resources on innovation and market growth. Vétalis specializes in precision bolus supplementation technology for livestock.
The collaboration aims to improve operational efficiencies while maintaining the market position of Tracesure® products in the UK and Ireland. The company expects the partnership to generate operational savings, though specific financial details were not disclosed.
"This is a key strategic milestone as we reposition the Group as a focused, pure-play agriculture business," said Joshua Hoopes, Chief Executive Officer of Carr’s Group.
Carr’s Group describes itself as a provider of livestock supplements. The partnership represents part of the company’s strategy to focus on its agricultural business segment while outsourcing certain manufacturing operations.
The press release indicates the partnership will support the development of products aimed at improving on-farm productivity and sustainable farming practices.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.